Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.770
+0.540 (24.22%)
At close: Jun 26, 2026, 4:00 PM EDT
2.770
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Pyxis Oncology Employees
Pyxis Oncology had 56 employees as of December 31, 2025. The number of employees increased by 12 or 27.27% compared to the previous year.
Employees
56
Change (1Y)
12
Growth (1Y)
27.27%
Revenue / Employee
$247,464
Profits / Employee
-$1,459,554
Market Cap
175.49M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56 | 12 | 27.27% |
| Dec 31, 2024 | 44 | -6 | -12.00% |
| Dec 31, 2023 | 50 | -25 | -33.33% |
| Dec 31, 2022 | 75 | 19 | 33.93% |
| Dec 31, 2021 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Innate Pharma | 164 |
| LENZ Therapeutics | 152 |
| Caribou Biosciences | 97 |
| Precision BioSciences | 66 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 49 |
| OnKure Therapeutics | 45 |
PYXS News
- 23 days ago - Pyxis Oncology Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Pyxis Oncology Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 5 weeks ago - Pyxis Oncology Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Pyxis Oncologyreports Q1 EPS (37c), consensus (35c) - TheFly
- 6 weeks ago - Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones - GlobeNewsWire
- 6 weeks ago - Pyxis Oncology Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Pyxis Oncology Earnings release: Q1 2026 - Filings
- 6 weeks ago - Pyxis Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire